Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells

Cancer Research

Volumn 56, Issue 24, 1996, Pages 5765-5770

  Gallegos, Alfred ^a   Gasdaska, John R ^a   Taylor, Charles W ^a   Paine Murrieta, Gillian D ^a   Goodman, Daniel ^a   Gasdaska, Pamela Y ^a   Berggren, Margareta ^a   Briehl, Margaret M ^b   Powis, Garth ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THIOREDOXIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CELL PROLIFERATION; GENETIC TRANSFECTION; GROWTH REGULATION; HUMAN; HUMAN CELL; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL;

3T3 CELLS; ANIMALS; BREAST NEOPLASMS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CYSTEINE; GENETIC VECTORS; HUMANS; MICE; MUTATION; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; PHENOTYPE; SERINE; THIOREDOXIN; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029778527     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Laurent, T. C., Moore, E. C., and Reichard, P Enzymatic synthesis of deoxyribonucleotides VI. Isolation and characterization of thioredoxin, the hydrogen donor from Escherichia coli B. J. Biol. Chem., 239: 3436-3444, 1964.
2. Hayashi, T , Ueno, Y., and Okamoto, T Oxidoreductive regulation of nuclear factor κB: involvement of a cellular reducing catalyst thioredoxin. J Biol Chem., 268: 11380-11388, 1993.
3. Gnppo, J. F., Tienrungroj, W , Dahmer, M. K , Housley, P. R , and Pratt, W B Evidence that the endogenous heat-stable glucocorticoid receptor-activating factor is thioredoxin J. Biol. Chem , 258, 13658-13664, 1983.
4. Abate, C., Patel, L., Rauscher F. J., III, and Curran, T. Redox regulation of fos and jun DNA-binding activity in vitro. Science (Washington DC), 249: 1157-1161, 1990.
5. Gasdaska, P. Y., Oblong, J. E., Cotgreave, I A., and Powis, G. The predicted amino acid sequence of human thioredoxin is identical to that of the autocrine growth factor human adult T-cell derived factor (ADF): thioredoxin mRNA is elevated in some human tumors. Biochim. Biophys. Acta, 1218: 292-296, 1994
6. Deiss, L P., and Kimchi, A. A genetic tool used to identify thioredoxin as a mediator of a growth inhibitory signal. Science (Washington DC), 252, 117-120, 1991
7. Tagaya, Y., Okada, M , Sugie, K , Kasahara, T., Kondo, N., Hamuro, J., Matsushima, K., Dinarello, C. A., and Yodoi, J. IL-2 receptor(p55)/TAC-inducing factor purification and characterization of adult T cell leukemia-derived factor. J. Immunol , 140: 2614-2620, 1988
8. Wakasugi, N., Tagaya, Y , Wakasugi, A , Mitsui, M , Maeda, M , Yodoi, J , and Tursz, T. Adult T-cell leukemia-derived factor/thioredoxin produced by both human T-lymphotropic virus type 1 and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergized with interleukin-1 and interleukin-2 Proc Natl. Acad Sci. USA, 87: 8282-8286, 1990.
9. Yodoi, J , and Tursz, T. ADF, a growth-promoting factor derived from adult T cell leukemia and homologous to thioredoxin: involvement in lymphocyte immortalization by HTLV-1 and EBV. Adv. Cancer Res., 57: 381-411, 1991.
10. Oblong, J. E , Berggren, M., Gasdaska, P Y., and Powis, G. Site-directed mutagenesis of active site cysteines in human thioredoxin produces competitive inhibitors of human thioredoxin reductase and elimination of mitogenic properties of thioredoxin. J. Biol. Chem., 269: 11714-11720, 1994.
11. Gasdaska, J. R., Berggren, M., and Powis, G. Cell growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism Cell Growth & Differ., 6: 1643-1650, 1995.
12. Tagaya, Y., Maeda, Y., Mitsui, A., Kondo, N., Matsui, H., Hamuro, J , Brown, N., Arai, K-I., Yokota, T., Wakasugi, H., and Yodoi, J. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin: possible involvement of dithiol-reduction in the IL-2 receptor induction EMBO J., 8: 757-764, 1989.
13. Berggren, M., Gallegos, A., Gasdaska, J R., Gasdaska, P Y., Warneke, J., and Powis, G. Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia. Anticancer Res., in press. 1996.
14. Fujii, S., Nanbu, Y., Nonogaki, H , Konishi, I , Mori, T , Masutani, H., and Yodoi, J. Coexpression of adult T-cell leukemia-derived factor, a human thioredoxin homologue, and human papillomavirus DNA in neoplastic cervical squamous epithelium Cancer (Phila.), 68, 1583-1591, 1991.
15. Nakamura, H., Masutani, H , Tagaya, Y., Yamauchi, A., Inamoto, T., Nanbu, Y., Fujii, S., Ozawa, K., and Yodoi, J. Expression and growth-promoting effect of adult T-cell leukemia-derived factor. A human thioredoxin homologue in hepatocellular carcinoma. Cancer (Phila.), 69: 2091-2097, 1992
16. Ericson, M L., Hörling, J , Wendel-Hansen, V , Holmgren, A., and Rosen, A. Secretion of thioredoxin after in vitro activation of human B cells. Lymphokine Cytokine Res , 11: 201-207, 1992.
17. Rubartelli, A., Bajetto, A , Allavena, G , Wollman, E , and Sitia, R. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J. Biol. Chem., 267: 24161-24164, 1992
18. Rubartelli, A., Bonifaci, N , and Sitia, R. High rates of thioredoxin secretion correlate with growth arrest in hepatoma cells Cancer Res., 55: 675-680, 1995.
19. Dieken, E S., and Miesfeld, R L. Transcriptional transactivation functions localized to the glucocorticoid receptor N terminus are necessary for steroid induction of lymphocyte apoptosis. Mol. Cell. Biol., 12: 589-597, 1992.
20. Gordon, D. A., Chamberlain, N. L., Flomerfelt, F A , and Miesfeld, R. L. A cell-specific and selective effector on transactivation by the androgen receptor Exp. Cell Res., 217: 368-377, 1995.
21. Alley, M C, and Lieber, M. M. Measurement of human tumor cell growth in soft-agar cultures using computer assisted volume analysis Br J Cancer, 52: 205-224, 1985
22. Powis, G , Lee-See, K , Santone, K S , Melder, D C , and Hodnett, E. M Quinoneimines as substrates for quinone reductase (NAD(P)H:(quinone-acceptor) oxidoreductase) and the effect of dicumarol on their cytotoxicity Biochem. Pharmacol , 36: 2473-2479, 1987.
23. Geran, R. I., Greenberg, N. H., Macdonald, M. M., Schumacher, A. M , and Abbott, B. J Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother. Rep., 3: 1-103, 1972.
24. Pitot, H. C. Fundamentals of Oncology, p. 149. New York: Marcel Dekker, Inc , 1981.
25. Schlager, J J., Hoerl, B. J., Riebow, J , Scott, D. P., Gasdaska, P., Scott, R. E., and Powis, G Increased NADPH.(quinone-acceptor) oxidoreductase (DT-diaphorase) activity is associated with density-dependent growth inhibition of normal but not transformed cells. Cancer Res., 53: 1338-1342, 1993.
26. Shultz, L. D Immunological mutants of the mouse. Am. J. Anat., 191: 303-311, 1991.
27. Weichsel, A., Gasdaska, J. R., Powis, G., and Montfort, W. R. Crystal structures of reduced, oxidized, and mutated human thioredoxins evidence for a regulatory homodimer Structure, in press, 1996.
28. Ifversen, P , Zhang, X M., Ohlin, M., Zeuthen, J., and Borrebaeck, C. A. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines. Hum Antib. Hybrid , 4: 115-123, 1993.
29. Powis, G., Gasdaska, P. Y., Gallegos, A , Sherrill, K , and Goodman, D. Overexpression of DT-diaphorase in transfected NIH 3T3 cells does not lead to increased anticancer quinone drug sensitivity: a questionable role for the enzyme as a target for bioreductively activated anticancer drugs. Anticancer Res , 15: 1141-1146, 1995
30. Gasdaska, P., Oblong, J E., and Powis, G. Cloning and expression of thioredoxin (T) cDNA from human colon cancer cells. Identity with ADF and levels of T mRNA in human tumors. Proc. Am Assoc. Cancer Res., 34: 62, 1993.
31. Mau, B-L , and Powis, G. Inhibition of cellular thioredoxin reductase by diaziquone and doxorubicin Biochem Pharmacol., 43: 1621-1626, 1992.
32. Powis, G. Metabolism and reactions of quinoid anticancer agents. Pharmacol Ther , 35: 157-162, 1987.